These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17962624)

  • 21. [The renin-angiotensin system and post-ischemic angiogenesis].
    Silvestre JS; Lévy BI
    Bull Acad Natl Med; 2004; 188(4):649-59; discussion 659. PubMed ID: 15587684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
    Liu XP; Pang YJ; Zhu WW; Zhao TT; Zheng M; Wang YB; Sun ZJ; Sun SJ
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):287-96. PubMed ID: 19018797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired coronary collateral growth in the metabolic syndrome is in part mediated by matrix metalloproteinase 12-dependent production of endostatin and angiostatin.
    Dodd T; Wiggins L; Hutcheson R; Smith E; Musiyenko A; Hysell B; Russell JC; Rocic P
    Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1339-49. PubMed ID: 23599440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pioglitazone inhibits angiotensin II-induced senescence of endothelial progenitor cell.
    Imanishi T; Kobayashi K; Kuroi A; Ikejima H; Akasaka T
    Hypertens Res; 2008 Apr; 31(4):757-65. PubMed ID: 18633188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of oxidative stress in the natriuresis induced by central administration of angiotensin II.
    Israel A; Arzola J; De Jesús S; Varela M
    J Renin Angiotensin Aldosterone Syst; 2009 Mar; 10(1):9-14. PubMed ID: 19286753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TGF-beta inhibits Ang II-induced MAPK p44/42 signaling in vascular smooth muscle cells by Ang II type 1 receptor downregulation.
    Meijering BD; van der Wouden EA; Pelgröm V; Henning RH; Sharma K; Deelman LE
    J Vasc Res; 2009; 46(5):459-68. PubMed ID: 19204403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amplification of coronary arteriogenic capacity of multipotent stromal cells by epidermal growth factor.
    Belmadani S; Matrougui K; Kolz C; Pung YF; Palen D; Prockop DJ; Chilian WM
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):802-8. PubMed ID: 19342596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimulation of coronary collateral growth by granulocyte stimulating factor: role of reactive oxygen species.
    Carrão AC; Chilian WM; Yun J; Kolz C; Rocic P; Lehmann K; van den Wijngaard JP; van Horssen P; Spaan JA; Ohanyan V; Pung YF; Buschmann I
    Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1817-22. PubMed ID: 19542022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Roles of Bone Marrow-Derived Stem Cells in Coronary Collateral Growth Induced by Repetitive Ischemia.
    Enrick M; Jamaiyar A; Ohanyan V; Juguilon C; Kolz C; Shi X; Janota D; Wan W; Richardson D; Stevanov K; Hakobyan T; Shockling L; Diaz A; Usip S; Dong F; Zhang P; Chilian WM; Yin L
    Cells; 2023 Jan; 12(2):. PubMed ID: 36672176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Redox-dependent mechanisms in coronary collateral growth: the "redox window" hypothesis.
    Yun J; Rocic P; Pung YF; Belmadani S; Carrao AC; Ohanyan V; Chilian WM
    Antioxid Redox Signal; 2009 Aug; 11(8):1961-74. PubMed ID: 19416057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ecSOD controls the delicate balance of reactive oxygen species in bone marrow and ischemic tissue needed for neovascularization.
    Wolin MS
    Circ Res; 2007 Aug; 101(4):331-2. PubMed ID: 17702978
    [No Abstract]   [Full Text] [Related]  

  • 32. Are Thiols Useful Biomarkers for Coronary Collateral Circulation in Patients with Stable Coronary Artery Disease?
    Doğan Y; Yilmaz Y; Kelesoğlu S; Calapkorur B; Neşelioglu S; Erel Ö; Kalay N
    J Clin Med; 2023 Oct; 12(19):. PubMed ID: 37835005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular function in male and female JCR:LA-cp rats: effect of high-fat/high-sucrose diet.
    Hunter I; Soler A; Joseph G; Hutcheson B; Bradford C; Zhang FF; Potter B; Proctor S; Rocic P
    Am J Physiol Heart Circ Physiol; 2017 Apr; 312(4):H742-H751. PubMed ID: 28087518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated 20-HETE impairs coronary collateral growth in metabolic syndrome via endothelial dysfunction.
    Joseph G; Soler A; Hutcheson R; Hunter I; Bradford C; Hutcheson B; Gotlinger KH; Jiang H; Falck JR; Proctor S; Schwartzman ML; Rocic P
    Am J Physiol Heart Circ Physiol; 2017 Mar; 312(3):H528-H540. PubMed ID: 28011587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of Comorbidities Associated With the Metabolic Syndrome: Insights from the
    Diane A; Pierce WD; Kelly SE; Sokolik S; Borthwick F; Jacome-Sosa M; Mangat R; Pradillo JM; Allan SM; Ruth MR; Field CJ; Hutcheson R; Rocic P; Russell JC; Vine DF; Proctor SD
    Front Nutr; 2016; 3():44. PubMed ID: 27777929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The NRF2 knockout rat: a new animal model to study endothelial dysfunction, oxidant stress, and microvascular rarefaction.
    Priestley JR; Kautenburg KE; Casati MC; Endres BT; Geurts AM; Lombard JH
    Am J Physiol Heart Circ Physiol; 2016 Feb; 310(4):H478-87. PubMed ID: 26637559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-21-mediated decreased neutrophil apoptosis is a determinant of impaired coronary collateral growth in metabolic syndrome.
    Hutcheson R; Terry R; Hutcheson B; Jadhav R; Chaplin J; Smith E; Barrington R; Proctor SD; Rocic P
    Am J Physiol Heart Circ Physiol; 2015 Jun; 308(11):H1323-35. PubMed ID: 25840830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-21 normalizes vascular smooth muscle proliferation and improves coronary collateral growth in metabolic syndrome.
    Hutcheson R; Chaplin J; Hutcheson B; Borthwick F; Proctor S; Gebb S; Jadhav R; Smith E; Russell JC; Rocic P
    FASEB J; 2014 Sep; 28(9):4088-99. PubMed ID: 24903275
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.